pubmed-article:11128633 | pubmed:abstractText | Solution-phase combinatorial chemistry was applied to the optimization and development of clinical candidate OC144-093 (22), a novel and nontoxic modulator of P-glycoprotein mediated multidrug resistance. | lld:pubmed |